And just to add, the PR’s save about 3-6 months in review time. They are valuable if you are competing for marketing approval with a competitors review process.
First to market.
Ann: Positive Guidance from FDA on Phase 3 Prostate Cancer Trial, page-51
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$5.80 |
Change
0.230(4.13%) |
Mkt cap ! $1.735B | |||
| Open | High | Low | Value | Volume |
| $5.68 | $5.88 | $5.68 | $1.701M | 293.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 2469 | $5.79 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.80 | 1663 | 1 |
View Market Depth
| Last trade - 10.40am 12/07/2024 (20 minute delay) ? |
| CU6 (ASX) Chart |